Transcatheter aortic valve implantation: Present and development trend / 中南大学学报(医学版)
Journal of Central South University(Medical Sciences)
;
(12): 991-996, 2017.
Artículo
en Chino
| WPRIM
| ID: wpr-607530
ABSTRACT
Currently,although surgical aortic valve replacement (SAVR) is still the golden standard in treatment of severe aortic stenosis according to the guideline,transcatheter aortic valve implantation (TAVI) is gradually becoming a common treatment for patients who are prohibitive or in high risk for SAVR.Recently,the valve manufacturers,including medical companies in China,are making their utmost to develop valve device,leading remarkable results achieved by TAVI.With the complications being controlled,TAVI displays promising future.It is likely that TAVI is expected to become a substitute for SAVR to treat patients with aortic stenosis or even aortic regurgitation.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Guía de Práctica Clínica
Idioma:
Chino
Revista:
Journal of Central South University(Medical Sciences)
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS